U.S. markets closed

Proteomics International Laboratories Limited (PIQ.AX)

ASX - ASX Delayed Price. Currency in AUD
0.90000.0000 (0.00%)
At close: 03:58PM AEST

Proteomics International Laboratories Limited

QEII Medical Centre
QQ Block 6 Verdun Street Nedlands
Perth, WA 6009
61 8 9389 1992

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London)Co-Founder, MD & Director442kN/AN/A
Ms. Jacqueline GrayChief Financial Officer261.95kN/AN/A
Mr. John Chuck MorrisonHead of Bus. Devel.N/AN/AN/A
Dr. Scott BringansHead of ResearchN/AN/AN/A
Dr. Pearl TanHead of LogisticsN/AN/AN/A
Mr. Vikesh MalikChief Commercialisation OfficerN/AN/AN/A
Dr. Kirsten PetersHead of Clinical StudiesN/AN/AN/A
Ms. Karen Teresa Logan ACIS, B.Com., BCom, DipAppCorpGov, F Fin, FCIS, FCCompany Sec.N/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.

Corporate Governance

Proteomics International Laboratories Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.